A CU Medicine provider.
Locations
720.848.0000Qualifications and experience
- Specialties
- Clinical Pharmacology
- Gender
- Male
- Languages spoken
-
English
- Education
-
Fellowship
University of California (San Francisco) School of Medicine Program
Internship
Los Angeles County-Harbor-UCLA Medical Center Program
Medical School
Harvard Medical School (1969)
Residency
Los Angeles County-Harbor-UCLA Medical Center Program
Undergraduate
Harvard University (MA)
- Clinical interest for patients
-
I am interested in Parkinson's Disease and Neuropharmacology.
- Research interest for patients
-
Research in my laboratory has focused on improving treatments for Parkinson's disease. In 1988, we performed the first transplant of dopamine-producing brain cells into an American patient with Parkinson's. We have done more brain cell transplants than any other group. While the transplanted cells can replace the need to take drugs like L-DOPA, they do not stop the relentless progression of the underlying disease. In 2006, we began the search for a drug to stop Parkinson’s and have found phenylbutyrate. In animal testing, phenylbutyrate can prevent Parkinson’s from advancing. We are now testing phenylbutyrate in patients and should know in the next few years if it is able to stop the progression of Parkinson's disease in people.
- Insurance
- UCHealth strongly encourages you to consult with your health insurer to determine accurate information about your coverage and benefits for a particular health care service provided at a UCHealth facility. Read more here.